ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.67
      0.00%
      US Tech 100
      17,586.00
      -0.15%
      Dow Jones
      39,056.39
      0.44%
      Brent Oil
      83.56
      0.84%
      Bitcoin
      61,132.15
      -1.93%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Accelerated Pharma (MM) (ACCP)

      7. Accelerated Pharma (MM) (ACCP) News

      ACCP

      ACCELERATED PHARMA, INC. (ACCP)

      Accelerated Pharma (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACCP
      DateTimeSourceHeadlineSymbolCompany
      1:05PMiHub NewswireFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
      04/22/202012:45PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACCPAccelerated Pharma (MM)
      02/06/20209:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACCPAccelerated Pharma (MM)
      02/05/202011:33AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACCPAccelerated Pharma (MM)
      11/08/20196:00AMEdgar (US Regulatory)Effectiveness Order (effect)NASDAQ:ACCPAccelerated Pharma (MM)
      11/06/20196:06AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
      10/21/20196:02AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
      07/24/20196:02AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
      01/25/20194:29PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
      10/22/20186:06AMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ACCPAccelerated Pharma (MM)
      08/23/201712:10PMEdgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ACCPAccelerated Pharma (MM)
      07/12/20175:27PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
      06/30/20176:04AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
      04/26/20176:03AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
      04/18/20172:22PMEdgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ACCPAccelerated Pharma (MM)
      04/18/201712:59PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
      03/28/20172:18PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
      12/12/20161:27PMEdgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ACCPAccelerated Pharma (MM)
      12/12/20168:31AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
      02/04/20109:00AMPR Newswire (US)Access Pharmaceuticals Initiates Program Applying Cobalamin Platform to siRNA Drug DeliveryNASDAQ:ACCP
      02/02/20103:22PMPR Newswire (US)Access Pharmaceuticals Announces Closing of $6.3 Million in Registered Direct OfferingNASDAQ:ACCP
      01/22/20109:29AMPR Newswire (US)Access Pharmaceuticals Raises $6.3 Million In Registered Direct OfferingNASDAQ:ACCP
      01/19/20109:00AMPR Newswire (US)Access Pharmaceutical's Cobalamin Oral Insulin Achieves Greater Than 80% Oral Bioavailability In Preclinical ModelsNASDAQ:ACCP
      01/07/20108:30AMPR Newswire (US)Access Pharmaceuticals Announces Completion of ProLindac Monotherapy Trial and Initiation of Combination StudyNASDAQ:ACCP
      01/06/20109:00AMPR Newswire (US)Access Pharmaceuticals To Present at OneMedPlace Forum 2010NASDAQ:ACCP
      12/15/20099:00AMPR Newswire (US)Access Pharmaceuticals Appoints Sales and Marketing ExecutiveNASDAQ:ACCP
      12/03/200912:48PMPR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch in EuropeNASDAQ:ACCP
      11/17/20099:00AMPR Newswire (US)ChangeWave Issues Buy Recommendation on Access PharmaceuticalsNASDAQ:ACCP
      11/11/20099:00AMPR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North AmericaNASDAQ:ACCP
      10/15/20098:00AMPR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians FeedbackNASDAQ:ACCP
       Showing the most relevant articles for your search:NASDAQ:ACCP